Skip to main content
HYFT
NASDAQ Life Sciences

Two Insiders Acquire $73K in HYFT Shares, Signaling Confidence

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$1.16
Mkt Cap
$54.186M
52W Low
$0.316
52W High
$3.246
52W Position info
267% above low
Off High info
64% below high
Rel. Volume info
0.2× avg
Market data snapshot near publication time

HYFT has more than doubled off its 52-week low of $0.316 on light trading volume (0.2× avg).

Summary

Two insiders at MindWalk Holdings Corp. collectively purchased 60,000 common shares for $73,238 in open market transactions over three consecutive days, indicating positive sentiment.


Key Events · Ownership and Investor Activity · HYFT

  • Significant Insider Buying

    Two insiders, Dirk M.H. Van Hyfte and Ingrid M.H. Brands, collectively acquired 60,000 common shares through open market purchases.

  • Substantial Capital Deployment

    A total of $73,238 was invested by the insiders in these transactions, occurring over three consecutive trading days from March 16-18, 2026.

  • Voluntary Disclosure for US Market

    This 6-K filing provides US market participants with visibility into transactions reported on Canada's System for Electronic Disclosure by Insiders (SEDI), as the company is exempt from US Form 4 requirements.


Analysis · HYFT · Life Sciences

This 6-K filing voluntarily discloses that two insiders, Dirk M.H. Van Hyfte and Ingrid M.H. Brands, collectively purchased 60,000 common shares of MindWalk Holdings Corp. for a total of $73,238 in open market transactions between March 16-18, 2026. The cluster buying activity over three consecutive days, while not a massive sum, represents a notable commitment of capital for a company of this size and suggests a positive outlook from those closest to the company's operations. This insider buying provides a positive signal to investors, especially following the recent Q3 earnings reports.

At the time of this filing, HYFT was trading at $1.16 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $54.2M. The 52-week trading range was $0.32 to $3.25. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

HYFT - Latest Insights

HYFT
Jul 22, 2026, 6:36 PM EDT
Filing Type: 20-F
Importance Score:
9
Price at Filing: $1.28
Real-time Price: $1.34 info
Change: +$0.060 (+5%) info
Market Cap: $62.963M info
HYFT
Jul 22, 2026, 4:59 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $1.40
Real-time Price: $1.34 info
Change: -$0.060 (-4%) info
Market Cap: $62.963M info
HYFT
Jul 22, 2026, 4:54 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $1.42
Real-time Price: $1.34 info
Change: -$0.0814 (-6%) info
Market Cap: $62.963M info
HYFT
Jul 06, 2026, 10:10 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $1.58
Real-time Price: $1.34 info
Change: -$0.235 (-15%) info
Market Cap: $62.963M info
HYFT
Jul 01, 2026, 9:54 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $1.59
Real-time Price: $1.34 info
Change: -$0.250 (-16%) info
Market Cap: $62.963M info